source
- Roche delays European filing of breast-cancer pill giredestrant amid US pricing pressuresRoche announced it will now seek European approval for its investigational breast cancer oral therapy giredestrant later than previously planned. The delay reflects the impact of U.S. drug pricing…
- Merck highlights oncology pipeline and cancer vaccine trial at ESMO 2026Merck attended the European Society for Medical Oncology (ESMO) meeting in Madrid, using the conference to present updates on its oncology portfolio. Media coverage largely centered on the company…